“LEQEMBI” (Lecanemab) Approved for the Treatment of Early Alzheimer’s Disease in Mexico
TOKYO and CAMBRIDGE, Mass., Dec 5, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the Federal Commission forthe Protection Against Sanitary Risk … Read More